Dr Lal PathLabs Ltd.
SET SMS ALERT
| 5-Day | 5,969 |
| 10-Day | 3,717 |
| 30-Day | 4,330 |
| 5-Day | 5,969 |
| 10-Day | 3,717 |
| 30-Day | 4,330 |
Depth
Market Depth (16 Aug 2019)
| BUY | SELL | ||
|---|---|---|---|
| QTY | PRICE | PRICE | QTY |
| 50 | 1190.05 | 1191.80 | 150 |
| 55 | 1185.00 | 1192.00 | 5 |
| 51 | 1183.40 | 1192.80 | 99 |
| 100 | 1180.15 | 1193.90 | 99 |
| 1 | 1162.80 | 1194.00 | 100 |
| 396 | Total | 3125 | Total |
Buy Qty
396
Sell QTY
3125
| 5-Day | 110,268 |
| 10-Day | 94,670 |
| 30-Day | 74,856 |
| 5-Day | 110,268 |
| 10-Day | 94,670 |
| 30-Day | 74,856 |
- Quote
- CHARTS
- NEWS
- COMMENTS3 new
- ANNOUNCEMENTS
- CORPORATE ACTION
- FINANCIALS
- ANNUAL REPORT
- SHAREHOLDING
- PEERS
- COMPANY INFO
- ALERTS
- Widgets
- BROKER
RESEARCH
Dr Lal PathLab
Sentimeter
100% of moneycontrol users recommend buying Dr Lal PathLab.
What's your call on Dr Lal PathLab today?
Read 3 investor views
| Days | BSE | NSE |
| 30 | 1094.53 | 1094.33 |
| 50 | 1093.36 | 1093.49 |
| 150 | 1054.33 | 1055.87 |
| 200 | 1017.39 | 1018.59 |
Click here to view the Open, High, Low, Close, Volume and Spread data for Dr Lal PathLab
| Standalone | Jun'19 | Mar'19 | Dec'18 | Sep'18 |
| Net Sales | 324.50 | 292.00 | 282.80 | 307.20 |
| Other Income | 14.10 | 13.00 | 11.90 | 10.70 |
| PBDIT | 91.90 | 64.10 | 62.60 | 83.20 |
| Net Profit | 57.30 | 46.00 | 44.30 | 55.20 |
(In Rs Cr)
| Total Share Capital | 83.34 |
| Net Worth | 930.83 |
| Total Debt | 0.00 |
| Net Block | 172.96 |
| Investments | 214.05 |
| Total Assets | 930.85 |
| Company Name | Last Price | % Change |
52 wk High |
52 wk Low |
Market Cap |
| Sun Pharma | 414.75 | -0.55 | 678.80 | 350.40 | 99,512.42 |
| Dr Reddys Labs | 2492.80 | -0.73 | 2965.20 | 2065.30 | 41,408.86 |
| Divis Labs | 1506.50 | -1.54 | 1768.80 | 1151.10 | 39,992.84 |
| Cipla | 476.25 | -0.47 | 678.00 | 465.50 | 38,380.42 |
| Ranbaxy Labs | 859.90 | 0.00 | 869.00 | 414.40 | 36,602.80 |
| More » | |||||
| Jun' 19 | Mar' 19 | Dec' 18 | Dec' 18 | |
| Promoter | 56.91 | 56.91 | 56.91 | 56.91 |
| Public (FII + DII) | 41.89 | 41.89 | 41.88 | 41.88 |
| Others | 1.20 | 1.20 | 1.21 | 1.21 |
| Total | 100.00 | 100.00 | 100.00 | 100.00 |
| Scheme | No. of Shares |
| UTI Equity Fund (G) | 1,446,333 |
| Franklin India Smaller Companies Fund (G) | 885,284 |
| Mirae Asset Emerging Bluechip Fund (G) | 847,878 |
| UTI Unit Linked Insurance Plan | 349,197 |
WPIL Recommended on Apr 26th 2017
Recommended price 458.00 | Peak from reco 1000.00 118.36%
What are Multi baggers?
Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.
About Dr Lal PathLab
Dr Lal PathLab is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 9,812.22 crore.
The company management includes Arvind Lal - Chairman & Managing Director, Om Prakash Manchanda - WholeTime Director & CEO, Vandana Lal - Whole Time Director, Rahul Sharma - Non Executive Director, Anoop Mahendra Singh - Independent Director, Sunil Varma - Independent Director, Harneet Singh Chandhoke - Independent Director, Saurabh Srivastava - Independent Director, Somya Satsangi - Independent Director, Archana Lal Erdmann - Non Executive Director.
It is listed on the BSE with a BSE Code of 539524 and the NSE with an NSE Code of LALPATHLAB.
Its Registered office is at Block E, Sector 18,,Rohini, New Delhi,Delhi - 110085.
Their Registrars are Link Intime India Pvt. Ltd.
